Chengjiang Wei

439 total citations
34 papers, 287 citations indexed

About

Chengjiang Wei is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chengjiang Wei has authored 34 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Chengjiang Wei's work include Neurofibromatosis and Schwannoma Cases (23 papers), Sarcoma Diagnosis and Treatment (14 papers) and Neuroblastoma Research and Treatments (7 papers). Chengjiang Wei is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (23 papers), Sarcoma Diagnosis and Treatment (14 papers) and Neuroblastoma Research and Treatments (7 papers). Chengjiang Wei collaborates with scholars based in China and United States. Chengjiang Wei's co-authors include Yihui Gu, Zhichao Wang, Bin Gu, Yuehua Li, Qingfeng Li, Xiang Lian, Tao Zan, Shuchen Gu, Yashan Gao and Xin Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Chengjiang Wei

33 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengjiang Wei China 7 103 71 52 52 50 34 287
Elisabeth Ohmann Germany 7 36 0.3× 106 1.5× 64 1.2× 99 1.9× 64 1.3× 7 491
Osama H. Ababneh Jordan 12 102 1.0× 133 1.9× 18 0.3× 8 0.2× 23 0.5× 25 540
John Reneau United States 7 19 0.2× 117 1.6× 23 0.4× 19 0.4× 49 1.0× 34 385
Mélanie Engelhardt Germany 8 27 0.3× 110 1.5× 33 0.6× 15 0.3× 14 0.3× 10 356
Ulrike Laß Germany 13 33 0.3× 213 3.0× 9 0.2× 46 0.9× 47 0.9× 20 453
Usue Etxaniz United States 8 26 0.3× 402 5.7× 26 0.5× 96 1.8× 17 0.3× 10 550
Hartmut Schwarze Germany 9 15 0.1× 88 1.2× 54 1.0× 36 0.7× 19 0.4× 12 435
Daniel Levi Italy 9 39 0.4× 125 1.8× 9 0.2× 12 0.2× 14 0.3× 15 393
Tara Karnezis Australia 5 61 0.6× 92 1.3× 5 0.1× 29 0.6× 14 0.3× 9 425

Countries citing papers authored by Chengjiang Wei

Since Specialization
Citations

This map shows the geographic impact of Chengjiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengjiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengjiang Wei more than expected).

Fields of papers citing papers by Chengjiang Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengjiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengjiang Wei. The network helps show where Chengjiang Wei may publish in the future.

Co-authorship network of co-authors of Chengjiang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Chengjiang Wei. A scholar is included among the top collaborators of Chengjiang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengjiang Wei. Chengjiang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yanan, Chengjiang Wei, Minghui Yue, et al.. (2025). From benign neurofibromas to malignant peripheral nerve sheath tumors (MPNST): a gaming among multiple factors. Cellular Oncology. 48(4). 841–857. 2 indexed citations
2.
Li, Yuehua, Jun Li, Jingxuan Huang, et al.. (2024). Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas. Cancer Letters. 599. 217151–217151. 3 indexed citations
3.
Li, Haibo, Chengjiang Wei, Luodan Yu, et al.. (2023). Multifunctional chemoreactive nanosonosensitizers exert antitumoral, antibacterial and wound healing effects on malignant peripheral nerve sheath tumors. Chemical Engineering Journal. 477. 147162–147162. 4 indexed citations
4.
Wang, Zhichao, et al.. (2023). Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single-cell RNA sequencing analysis. Cancer Immunology Immunotherapy. 72(12). 4415–4429. 6 indexed citations
5.
Wang, Zhichao, Dun Wang, Yuehua Li, et al.. (2023). Laser treatment for Cafe-au-lait Macules: a systematic review and meta-analysis. European journal of medical research. 28(1). 185–185. 2 indexed citations
6.
Zheng, Tingting, Wei Wang, Yihui Gu, et al.. (2023). Genotype–phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort. Journal of Neurology. 271(4). 1893–1900. 6 indexed citations
7.
Gu, Yihui, Chengjiang Wei, Haibo Li, et al.. (2023). FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner. Cancer Gene Therapy. 30(10). 1390–1402. 4 indexed citations
8.
Li, Yuehua, Chengjiang Wei, Yihui Gu, et al.. (2022). Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs. Cancers. 14(23). 5798–5798. 4 indexed citations
9.
Gu, Yihui, Zhichao Wang, Chengjiang Wei, et al.. (2022). Photonic hyperthermia of malignant peripheral nerve sheath tumors at the third near-infrared biowindow. eLife. 11. 6 indexed citations
10.
11.
Liu, Jun, et al.. (2022). Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1. Frontiers in Oncology. 12. 898971–898971. 6 indexed citations
12.
Gu, Yihui, Yuehua Li, Haibo Li, et al.. (2022). Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response. Frontiers in Oncology. 12. 903177–903177. 6 indexed citations
13.
Gu, Yihui, Chengjiang Wei, Haibo Li, et al.. (2022). Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors. Frontiers in Oncology. 12. 910505–910505. 7 indexed citations
14.
15.
Wang, Wei, Manmei Long, Chengjiang Wei, et al.. (2021). Clinical comparison of tenosynovial giant cell tumors, synovial chondromatosis, and synovial sarcoma: analysis and report of 53 cases. Annals of Translational Medicine. 9(13). 1059–1059. 2 indexed citations
16.
Gu, Yihui, Manmei Long, Chengjiang Wei, et al.. (2021). Selection of internal references for RT-qPCR assays in Neurofibromatosis type 1 (NF1) related Schwann cell lines. PLoS ONE. 16(2). e0241821–e0241821. 6 indexed citations
17.
Wang, Huijing, Wei Wang, Jun Lü, et al.. (2021). Distribution Patterns (7B Rule) and Characteristics of Large Congenital Melanocytic Nevi: A Retrospective Cohort Study in China. Frontiers in Medicine. 8. 637857–637857. 4 indexed citations
18.
Wang, Wei, Chengjiang Wei, Yuehua Li, et al.. (2021). Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1. Frontiers in Neurology. 12. 704639–704639. 41 indexed citations
19.
Gu, Yihui, Manmei Long, Chengjiang Wei, et al.. (2020). Protein Tyrosine Phosphatase Receptor S Acts as a Metastatic Suppressor in Malignant Peripheral Nerve Sheath Tumor via Profilin 1-Induced Epithelial-Mesenchymal Transition. Frontiers in Cell and Developmental Biology. 8. 582220–582220. 6 indexed citations
20.
Wei, Chengjiang, Yihui Gu, Wei Wang, et al.. (2020). A narrative review of the role of fibroblasts in the growth and development of neurogenic tumors. Annals of Translational Medicine. 8(21). 1462–1462. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Ohmann Breakdown of academic impact, for papers by Osama H. Ababneh Breakdown of academic impact, for papers by John Reneau Breakdown of academic impact, for papers by Mélanie Engelhardt Breakdown of academic impact, for papers by Ulrike Laß Breakdown of academic impact, for papers by Usue Etxaniz Breakdown of academic impact, for papers by Hartmut Schwarze Breakdown of academic impact, for papers by Daniel Levi Breakdown of academic impact, for papers by Tara Karnezis
Rankless by CCL
2026